Premier Path Wealth Partners LLC Cuts Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Premier Path Wealth Partners LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 14.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,957 shares of the medical research company’s stock after selling 319 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Agilent Technologies were worth $229,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC purchased a new stake in Agilent Technologies during the fourth quarter worth about $27,000. Lee Danner & Bass Inc. acquired a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $29,000. Sunbelt Securities Inc. boosted its stake in shares of Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock worth $30,000 after acquiring an additional 192 shares in the last quarter. Whipplewood Advisors LLC grew its holdings in shares of Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock worth $29,000 after acquiring an additional 186 shares during the period. Finally, Wood Tarver Financial Group LLC purchased a new position in Agilent Technologies in the 4th quarter valued at approximately $34,000.

Insider Buying and Selling at Agilent Technologies

In related news, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares of the company’s stock, valued at approximately $4,161,931.02. This represents a 4.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Analysts Set New Price Targets

A number of research firms have commented on A. Wells Fargo & Company decreased their target price on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. TD Cowen increased their price objective on shares of Agilent Technologies to $150.00 and gave the company a “buy” rating in a research note on Thursday, May 29th. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, June 14th. Robert W. Baird reduced their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating on the stock in a report on Thursday, May 22nd. Finally, Barclays dropped their price objective on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. Eight equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $140.15.

Agilent Technologies Trading Up 0.1%

Shares of Agilent Technologies stock opened at $115.61 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The business’s fifty day moving average is $110.67 and its two-hundred day moving average is $124.70. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The firm has a market cap of $32.84 billion, a PE ratio of 28.55, a P/E/G ratio of 3.51 and a beta of 1.23.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.05. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. During the same period last year, the company earned $1.22 EPS. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. Analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Tuesday, July 1st. Agilent Technologies’s dividend payout ratio is currently 24.44%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.